Overview

Reversing Corticosteroid Induced Memory Impairment

Status:
Completed

Trial end date:
2015-06-01

Target enrollment:

Participant gender:

Summary

Medically stable outpatients receiving chronic oral corticosteroid therapy were enrolled in a 48-week randomized, double-blind, placebo-controlled, parallel-group, trial of lamotrigine.

Phase:

Phase 4

Details

Lead Sponsor:

University of Texas Southwestern Medical Center

Collaborator:

National Institute of Mental Health (NIMH)

Treatments:

Anticonvulsants
Lamotrigine